Literature DB >> 7089960

Recycling of mast cells following degranulation in vitro: an ultrastructural study.

S J Burwen.   

Abstract

Mature mast cells, isolated from the rat peritoneal cavity, were placed into suspension culture, either as resting or after degranulation by exposure to compound 48/80, and were maintained for up to 63 hr. No mitotic cells were observed, and cell number was conserved. The culture conditions did not cause spontaneous degranulation and cell survival was better than 80%. However, with time in culture, an increasing percentage of cells acquired a vesiculated appearance, characterized by a Golgi area with distended cisternae, the accumulation of lysosomal or autophagic-like vesicles, and enlarged, irregular or fused secretory granules. In the degranulated group, about one-fourth of the cells recovered the morphological appearance of resting cells by 63 hr, indicating that they are capable of 'recycling'. A cell type with a unique morphology, characterized by a large central vacuole containing secretory product, an eccentric nucleus, and mature secretory granules at the cell periphery appeared in the stimulated group after 22 hr of culture. In may be a possible intermediate stage in the mast cell regranulation process, based on its occurrence exclusively in the stimulated group, the correlation between its distribution and the recovery of mast cells to the resting state, and the morphological resemblance of its granule contents to stages in granule maturation in differentiating embryonic mast cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7089960     DOI: 10.1016/0040-8166(82)90012-x

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  10 in total

1.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Mast cells retain their responsiveness upon continuous and repetitive exposure to antigen.

Authors:  M Shalit; D Pickholz; F Levi-Shaffer
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

3.  Fc gamma RI-mediated activation of human mast cells promotes survival and induction of the pro-survival gene Bfl-1.

Authors:  Mats Karlberg; Zou Xiang; Gunnar Nilsson
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

Review 4.  IgE and mast cells in host defense against parasites and venoms.

Authors:  Philipp Starkl; Thomas Marichal; Kaori Mukai; Mindy Tsai; Stephen J Galli
Journal:  Semin Immunopathol       Date:  2016-05-25       Impact factor: 9.623

5.  Activation of the Na+/K(+)-pump in rat peritoneal mast cells following histamine release: a possible role in cell recovery.

Authors:  T Knudsen; I Ferjan; T Johansen
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

Review 6.  Mast cell-orchestrated immunity to pathogens.

Authors:  Soman N Abraham; Ashley L St John
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 7.  Mast cells and influenza a virus: association with allergic responses and beyond.

Authors:  Amy C Graham; Rachel M Temple; Joshua J Obar
Journal:  Front Immunol       Date:  2015-05-18       Impact factor: 7.561

8.  Mast cell activation in the skin of Plasmodium falciparum malaria patients.

Authors:  Panop Wilainam; Rungrat Nintasen; Parnpen Viriyavejakul
Journal:  Malar J       Date:  2015-02-07       Impact factor: 2.979

Review 9.  Roles of Mast Cells in Cutaneous Diseases.

Authors:  Takafumi Numata; Kazutoshi Harada; Susumu Nakae
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

10.  Mitogen-Activated Protein Kinase Signaling Regulates Proteoglycan Composition of Mast Cell Secretory Granules.

Authors:  Jun Mei Hu Frisk; Lena Kjellén; Fabio R Melo; Helena Öhrvik; Gunnar Pejler
Journal:  Front Immunol       Date:  2018-07-19       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.